These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

646 related items for PubMed ID: 31761636

  • 1. Outcomes of Drug-Coated Balloon Angioplasty vs. Conventional Balloon Angioplasty for Endovascular Treatment of Common Femoral Artery Atherosclerotic Disease.
    Cantu D, Jawaid O, Kokkinidis D, Giannopoulos S, Valle JA, Waldo SW, Singh GD, Armstrong EJ.
    Cardiovasc Revasc Med; 2020 Jul; 21(7):867-874. PubMed ID: 31761636
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
    Imran HM, Hyder ON, Soukas PA.
    Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
    [Abstract] [Full Text] [Related]

  • 3. Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.
    Foley TR, Cotter RP, Kokkinidis DG, Nguyen DD, Waldo SW, Armstrong EJ.
    Catheter Cardiovasc Interv; 2017 May; 89(6):1078-1085. PubMed ID: 28295971
    [Abstract] [Full Text] [Related]

  • 4. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
    Reijnen MMPJ, van Wijck I, Zeller T, Micari A, Veroux P, Keirse K, Lee SW, Li P, Voulgaraki D, Holewijn S.
    J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions-Comparison with Sole Drug-coated Balloon Revascularization: Two-year Outcomes.
    Rodoplu O, Oztas DM, Meric M, Beyaz MO, Ulukan MO, Yildiz CE, Unal O, Ugurlucan M.
    Ann Vasc Surg; 2021 May; 73():222-233. PubMed ID: 33359329
    [Abstract] [Full Text] [Related]

  • 6. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis.
    Giannopoulos S, Kokkinidis DG, Jawaid O, Behan S, Hossain P, Alvandi B, Foley TR, Singh GD, Waldo SW, Armstrong EJ.
    Cardiovasc Revasc Med; 2020 Jun; 21(6):771-778. PubMed ID: 31761634
    [Abstract] [Full Text] [Related]

  • 7. Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis.
    Giannopoulos S, Ghanian S, Parikh SA, Secemsky EA, Schneider PA, Armstrong EJ.
    J Endovasc Ther; 2020 Aug; 27(4):647-657. PubMed ID: 32508220
    [Abstract] [Full Text] [Related]

  • 8. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Common Femoral Artery Atherosclerotic Disease.
    Stavroulakis K, Schwindt A, Torsello G, Beropoulis E, Stachmann A, Hericks C, Bollenberg L, Bisdas T.
    J Endovasc Ther; 2018 Feb; 25(1):92-99. PubMed ID: 29251204
    [Abstract] [Full Text] [Related]

  • 9. Rotational atherectomy with adjunctive balloon angioplasty in calcified chronic total occlusions of superficial femoral artery.
    Engin AY, Saydam O.
    Vascular; 2021 Oct; 29(5):682-692. PubMed ID: 33167805
    [Abstract] [Full Text] [Related]

  • 10. Two-Year Outcomes of Orbital Atherectomy Combined With Drug-Coated Balloon Angioplasty for Treatment of Heavily Calcified Femoropopliteal Lesions.
    Kokkinidis DG, Jawaid O, Cantu D, Martinsen BJ, Igyarto Z, Valle JA, Waldo SW, Armstrong EJ.
    J Endovasc Ther; 2020 Jun; 27(3):492-501. PubMed ID: 32364000
    [Abstract] [Full Text] [Related]

  • 11. Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort.
    Torsello G, Stavroulakis K, Brodmann M, Micari A, Tepe G, Veroux P, Benko A, Choi D, Vermassen FEG, Jaff MR, Guo J, Dobranszki R, Zeller T, IN.PACT Global Investigators.
    J Endovasc Ther; 2020 Oct; 27(5):693-705. PubMed ID: 32583749
    [Abstract] [Full Text] [Related]

  • 12. Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study.
    Zeller T, Langhoff R, Rocha-Singh KJ, Jaff MR, Blessing E, Amann-Vesti B, Krzanowski M, Peeters P, Scheinert D, Torsello G, Sixt S, Tepe G, DEFINITIVE AR Investigators.
    Circ Cardiovasc Interv; 2017 Sep; 10(9):e004848. PubMed ID: 28916599
    [Abstract] [Full Text] [Related]

  • 13. The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes.
    Zeller T, Micari A, Scheinert D, Baumgartner I, Bosiers M, Vermassen FEG, Banyai M, Shishehbor MH, Wang H, Brodmann M, IN.PACT DEEP Trial Investigators.
    JACC Cardiovasc Interv; 2020 Feb 24; 13(4):431-443. PubMed ID: 32081236
    [Abstract] [Full Text] [Related]

  • 14. One-Year Clinical Outcomes of the Legflow Drug-Coated Balloon for the Treatment of Femoropopliteal Occlusions Registry.
    Stabile E, Gerardi D, Magliulo F, Zhelev D, Chervenkoff V, Taeymans K, Kotasov D, Goverde P, Giugliano G, Trimarco B, Esposito G.
    J Endovasc Ther; 2019 Feb 24; 26(1):26-30. PubMed ID: 30760132
    [Abstract] [Full Text] [Related]

  • 15. Midterm Outcome of Directional Atherectomy Combined with Drug-Coated Balloon Angioplasty Versus Drug-Coated Balloon Angioplasty Alone for Femoropopliteal Arteriosclerosis Obliterans.
    Cai Z, Guo L, Qi L, Cui S, Tong Z, Guo J, Wang Z, Gu Y.
    Ann Vasc Surg; 2020 Apr 24; 64():181-187. PubMed ID: 31449956
    [Abstract] [Full Text] [Related]

  • 16. Three-Year Outcomes of Orbital Atherectomy for the Endovascular Treatment of Infrainguinal Claudication or Chronic Limb-Threatening Ischemia.
    Giannopoulos S, Secemsky EA, Mustapha JA, Adams G, Beasley RE, Pliagas G, Armstrong EJ.
    J Endovasc Ther; 2020 Oct 24; 27(5):714-725. PubMed ID: 32618486
    [Abstract] [Full Text] [Related]

  • 17. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.
    Stavroulakis K, Schwindt A, Torsello G, Stachmann A, Hericks C, Bosiers MJ, Beropoulis E, Stahlhoff S, Bisdas T.
    J Endovasc Ther; 2017 Apr 24; 24(2):181-188. PubMed ID: 28008792
    [Abstract] [Full Text] [Related]

  • 18. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
    Kokkinidis DG, Behan S, Jawaid O, Hossain P, Giannopoulos S, Singh GD, Laird JR, Valle JA, Waldo SW, Armstrong EJ.
    Catheter Cardiovasc Interv; 2020 Feb 15; 95(3):439-446. PubMed ID: 31816169
    [Abstract] [Full Text] [Related]

  • 19. Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions.
    Laird JA, Schneider PA, Jaff MR, Brodmann M, Zeller T, Metzger DC, Krishnan P, Scheinert D, Micari A, Wang H, Masters M, Tepe G.
    Circ Cardiovasc Interv; 2019 Jun 15; 12(6):e007702. PubMed ID: 31195825
    [Abstract] [Full Text] [Related]

  • 20. Amputation-free Survival in Patients with Critical Limb Ischemia Treated with Paclitaxel-eluting Stents and Paclitaxel-coated Balloons.
    Phair J, Carnevale M, Lipsitz EC, Shariff S, Scher L, Garg K.
    Ann Vasc Surg; 2020 Jan 15; 62():8-14. PubMed ID: 31207400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.